Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A 64-Week (12-week Core Phase and 52-week Safety Extension), Phase II, Multicenter, Randomized, Open Label Study to Evaluate the Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With
Brief Summary: The primary objective of this study is to evaluate the clinical effect of TV-1106.